In a report yesterday (September 14) by openPR (Hannover, Germany) promoting recent market research was an excerpt of information specifically related to the new nanocellulose-pharmaceutical relationship that has recently developed. It is expected to become more widespread in medical preparations of new drugs. This will provide a continued significant boost to the nanocellulose market through at least the near future.

 

This information is based on recent studies done by Transparency Market Research (TMR), Albany, N.Y. The market for nanocellulose technology, according to TMR, is experiencing burgeoning demand across pharmaceutical industry due to its use as excipients in formulation, for coating tablets, printing on hard capsules, and for advanced packaging purposes. Ongoing development in drug delivery is also driving the demand for nanocellulose materials; bacterial cellulose obtained from bacteria is considered to exert controlling influence on skin release of a drug. Increasing number of drugs showing poor solubility and bioavailability is also one of the factors creating the demand for nanocellulose.

 

Other factors driving the market for nanocellulose technology are its lowering cost, increasing demand for more efficacious drugs, and the substantial amount of ongoing research on nanocellulose to enhance its application spectrum. In developed countries, rapid growth in personalized medicine market fueling the demand for advanced drug delivery system can also be a factor driving the market. 

India, now holding the third rank in terms of pharmaceutical bulk manufacturing, also represents a potential new market for nanocellulose technology to be focused on.

 

Some of the major companies and research groups operating in the market for nanocellulose technology, according to TMR, include Grenoble INP-Pagora, Melodea, Nippon, Polynew Inc., Verso, SUNY-ESF, Oji Paper, UPM-Kymmene, U.S. Forest Service Products Laboratory, Stora Enso, Georgia Tech, and Diacel Chemical Ltd.